They analyzed a large set of thyroid cancer samples, both differentiated (Papillary carcinoma of the thyroid, n=69) and ATC (n=30) by immunohistochemistry, and found that Gal-3 levels decrease when papillary carcinoma lesions progress to ATC. Here, LGALS3 is linked to thyroid cancer.